Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.
Most patients with chronic rhinosinusitis with nasal polyps no longer used oral corticosteroids after using dupilumab, ...
In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...
InvestorsHub on MSN
Nektar Therapeutics Shares Rise After Positive Asthma Data in Atopic Dermatitis Patients
Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing ...
An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says.
One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported ...
Managing asthma effectively requires more than just keeping an inhaler nearby. This chronic respiratory condition affects approximately 25 million Americans, yet despite medical advances and improved ...
An asthma intervention helps patients, but may hurt hospitals. April 13, 2010— -- By taking steps outside the confines of their own facilities, more and more hospitals have been able to keep ...
Researchers found that thunderstorms lead to "sharp" increases in asthma-related hospital visits. The post Study finds ...
Spontaneous pneumomediastinum (SPM) refers to the presence of free air in the mediastinum without preceding trauma or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results